Mardi Dier - 12 Oct 2022 Form 4 Insider Report for Ultragenyx Pharmaceutical Inc. (RARE)

Role
CFO & Executive Vice President
Signature
/s/ Karah Parschauer, attorney-in-fact
Issuer symbol
RARE
Transactions as of
12 Oct 2022
Net transactions value
-$133,158
Form type
4
Filing time
14 Oct 2022, 12:58:31 UTC
Previous filing
19 Sep 2022
Next filing
17 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RARE Common Stock Sale $133,158 -3,484 -4.9% $38.22 68,324 12 Oct 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").
F2 Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.